Evista® 60 mg Tablets marketed by Eli Lilly and Company, had annual sales of approximately $824 million in the United States, according to IMS data as ofDecember 2013. About Teva ...

Edgemont Pharmaceuticals, LLC, a neuroscience focused company, announced that the US Food and Drug Administration (US FDA) has approved its New Drug Application (NDA) for fluoxetine tablets 60 mg.